TAKEDA PHARMACEUTICAL COMPANY LIMITED Toevoegen aan een lijst
Financiën Takeda Pharmaceutical Company Limited Nyse
Aandelen
TAK
US8740602052
Farmaceutische producten
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 13,1 USD | +0,15% |
|
-2,75% | -8,20% |
Totale waarde
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 7.029.161 | 5.153.364 | 6.229.971 | 5.423.454 | 6.762.204 | 6.498.524 | - | - |
| Bedrijfswaarde 1 | 12.054.743 | 9.609.054 | 9.862.522 | 8.919.170 | 10.611.015 | 10.950.330 | 10.687.037 | 10.335.859 |
| K/w-verhouding | 40 x | 118 x | 16,6 x | 23,8 x | 21,3 x | 45,4 x | 64,1 x | 28,4 x |
| Dividendrendement | 3,98% | 5,44% | 4,52% | 5,15% | 4,14% | 4,49% | 4,69% | 4,81% |
| Marktkapitalisatie/omzet | 3,35 x | 1,57 x | 1,95 x | 1,52 x | 1,68 x | 1,54 x | 1,52 x | 1,5 x |
| Bedrijfswaarde/omzet | 5,75 x | 2,92 x | 3,08 x | 2,5 x | 2,63 x | 2,57 x | 2,5 x | 2,38 x |
| Bedrijfswaarde/EBITDA | 25,3 x | 14 x | 9,23 x | 8,54 x | 9,19 x | 11,6 x | 9,7 x | 8,65 x |
| Bedrijfswaarde/FCF | -4,81 x | 9,99 x | 16 x | 8,92 x | 28,7 x | 43,4 x | 15,7 x | 15,7 x |
| FCF Yield | -20,8% | 10% | 6,26% | 11,2% | 3,49% | 2,31% | 6,39% | 6,38% |
| Price to Book | 1,36 x | 1,09 x | 1,2 x | 0,95 x | 1,06 x | 0,9 x | 0,92 x | 0,95 x |
| Aantal aandelen (in duizenden) | 1.554.780 | 1.557.849 | 1.563.355 | 1.550.444 | 1.554.530 | 1.568.934 | - | - |
| Referentieprijs 2 | 4.521 | 3.308 | 3.985 | 3.498 | 4.350 | 4.142 | 4.142 | 4.142 |
| Datum van publicatie | 14-05-19 | 13-05-20 | 11-05-21 | 11-05-22 | 11-05-23 | 09-05-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 2.097.200 | 3.291.200 | 3.197.812 | 3.569.006 | 4.027.478 | 4.263.762 | 4.268.729 | 4.339.235 |
| EBITDA 1 | 477.415 | 684.057 | 1.068.940 | 1.043.995 | 1.154.905 | 942.077 | 1.101.766 | 1.194.359 |
| Bedrijfsresultaat (EBIT) 1 | 205.000 | 100.400 | 509.269 | 460.844 | 490.505 | 214.100 | 292.184 | 434.785 |
| Operationele Marge | 9,77% | 3,05% | 15,93% | 12,91% | 12,18% | 5,02% | 6,84% | 10,02% |
| Resultaat voor belastingen (EBT) 1 | 94.896 | -60.754 | 366.235 | 302.571 | 375.090 | 52.791 | 112.443 | 304.432 |
| Nettowinst (verlies) 1 | 109.100 | 44.200 | 376.005 | 230.059 | 317.017 | 144.067 | 103.058 | 230.895 |
| Nettomarge | 5,2% | 1,34% | 11,76% | 6,45% | 7,87% | 3,38% | 2,41% | 5,32% |
| WPA 2 | 113,0 | 28,00 | 240,7 | 147,1 | 204,3 | 92,09 | 64,64 | 145,7 |
| Free Cash Flow 1 | -2.507.219 | 961.871 | 617.401 | 999.853 | 370.054 | 252.482 | 682.369 | 659.391 |
| FCF-marge | -119,55% | 29,23% | 19,31% | 28,01% | 9,19% | 5,92% | 15,99% | 15,2% |
| Kasstroomconversie (ebitda) | - | 140,61% | 57,76% | 95,77% | 32,04% | 26,8% | 61,93% | 55,21% |
| Kasstroomconversie (nettowinst) | - | 2.176,18% | 164,2% | 434,61% | 116,73% | 175,25% | 662,12% | 285,58% |
| Dividend per aandeel 2 | 180,0 | 180,0 | 180,0 | 180,0 | 180,0 | 188,0 | 194,3 | 199,3 |
| Datum van publicatie | 14-05-19 | 13-05-20 | 11-05-21 | 11-05-22 | 11-05-23 | 09-05-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Maart | 2020 S1 | 2020 S2 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 1.660.200 | 1.631.000 | 1.590.785 | 844.797 | 1.794.400 | 901.294 | 873.289 | 972.465 | 1.002.340 | 1.974.800 | 1.096.551 | 956.200 | 1.058.618 | 1.043.089 | 2.101.707 | 1.111.200 | 1.050.869 | 1.073.112 | 1.080.400 | 2.126.400 | 1.139.257 | 1.062.529 | 2.137.000 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | - | 249.972 | 340.072 | 133.355 | - | 291.975 | 176.675 | 320.925 | 282.725 | - | 368.925 | 202.525 | - |
| Bedrijfsresultaat (EBIT) 1 | 50.300 | 50.100 | 215.588 | 97.448 | 346.000 | 116.484 | -1.619 | 150.515 | 104.485 | 255.000 | 146.990 | 88.600 | 168.571 | -49.341 | 119.230 | 104.900 | -10.055 | 87.880 | 73.125 | 137.550 | 74.350 | 29.175 | 239.500 |
| Operationele Marge | 3,03% | 3,07% | 13,55% | 11,54% | 19,28% | 12,92% | -0,19% | 15,48% | 10,42% | 12,91% | 13,4% | 9,27% | 15,92% | -4,73% | 5,67% | 9,44% | -0,96% | 8,19% | 6,77% | 6,47% | 6,53% | 2,75% | 11,21% |
| Resultaat voor belastingen (EBT) 1 | -27.557 | -33.197 | 125.561 | 61.447 | 284.425 | 72.193 | -54.047 | 155.473 | 64.549 | 220.022 | 107.153 | 47.900 | 135.033 | -95.980 | 39.053 | 61.300 | -47.500 | 60.840 | 44.187 | 57.650 | 35.554 | -8.513 | 156.500 |
| Nettowinst (verlies) 1 | 33.200 | 11.000 | 86.548 | -16.778 | 183.600 | 57.769 | -11.358 | 105.014 | 61.786 | 166.800 | 119.127 | 31.100 | 89.395 | -48.030 | 41.365 | 105.700 | -3.000 | 54.116 | 40.154 | 59.800 | 33.654 | -2.013 | 120.500 |
| Nettomarge | 2% | 0,67% | 5,44% | -1,99% | 10,23% | 6,41% | -1,3% | 10,8% | 6,16% | 8,45% | 10,86% | 3,25% | 8,44% | -4,6% | 1,97% | 9,51% | -0,29% | 5,04% | 3,72% | 2,81% | 2,95% | -0,19% | 5,64% |
| WPA 2 | 21,00 | - | 55,45 | -10,27 | 117,0 | 37,01 | -6,950 | 67,94 | 40,06 | 108,0 | 76,70 | 20,03 | 57,51 | -31,00 | 26,51 | 67,38 | -1,920 | 32,13 | 23,80 | 47,50 | 24,35 | -6,569 | 76,80 |
| Dividend per aandeel 2 | 90,00 | - | 90,00 | - | 90,00 | - | - | - | - | - | - | - | - | 94,00 | 94,00 | - | 94,00 | - | - | - | - | - | - |
| Datum van publicatie | 31-10-19 | 13-05-20 | 29-10-20 | 28-10-21 | 28-10-21 | 03-02-22 | 11-05-22 | 28-07-22 | 27-10-22 | 27-10-22 | 02-02-23 | 11-05-23 | 27-07-23 | 26-10-23 | 26-10-23 | 01-02-24 | 09-05-24 | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 5.025.582 | 4.455.690 | 3.632.551 | 3.495.716 | 3.848.811 | 4.385.952 | 4.188.513 | 3.837.335 |
| Nettokaspositie 1 | - | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 10,53 x | 6,514 x | 3,398 x | 3,348 x | 3,333 x | 4,656 x | 3,802 x | 3,213 x |
| Free Cash Flow 1 | -2.507.219 | 961.871 | 617.401 | 999.853 | 370.054 | 252.482 | 682.369 | 659.391 |
| ROE (netto-inkomsten/eigen vermogen) | 3% | 0,9% | 7,6% | 4,2% | 5,3% | 2,1% | 1,42% | 3,17% |
| ROA (netto-inkomsten/totale activa) | 1,06% | -0,46% | 2,85% | 2,32% | 2,76% | 0,36% | 0,82% | 1,93% |
| Totale activa 1 | 10.334.963 | -9.710.018 | 13.209.937 | 9.918.859 | 11.467.260 | 39.661.656 | 12.574.212 | 11.944.912 |
| Nettoactief per aandeel 2 | 3.319 | 3.032 | 3.309 | 3.666 | 4.087 | 4.636 | 4.503 | 4.347 |
| Cashflow per aandeel 2 | 397,0 | 403,0 | 599,0 | 520,0 | 632,0 | 557,0 | 683,0 | 669,0 |
| Capex 1 | 134.114 | 217.710 | 236.468 | 186.037 | 633.689 | 480.730 | 646.300 | 291.364 |
| Capex/omzet | 6,39% | 6,61% | 7,39% | 5,21% | 15,73% | 11,27% | 15,14% | 6,71% |
| Datum van publicatie | 14-05-19 | 13-05-20 | 11-05-21 | 11-05-22 | 11-05-23 | 09-05-24 | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
18
Laatste slotkoers
4.142
JPY
Gemiddelde koersdoel
4.768
JPY
Spread / Gemiddelde doel
+15,11%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +50,70% | 791 mld. | |
| +41,96% | 630 mld. | |
| -7,15% | 350 mld. | |
| +18,77% | 328 mld. | |
| +8,79% | 298 mld. | |
| +18,02% | 246 mld. | |
| +1,27% | 225 mld. | |
| +11,95% | 218 mld. | |
| +3,68% | 160 mld. |
- Beurs
- Aandelen
- Koers 4502
- Koers TAK
- Financiën Takeda Pharmaceutical Company Limited
